Head of Scientific Research

Choi, Y. H., Kim, H. K., Hazekamp, A., Erkelens, C., Lefeber, A. W., & Verpoorte, R. (2004). Metabolomic Differentiation of Cannabis s ativa Cultivars Using 1H NMR Spectroscopy and Principal Component Analysis. Journal of natural products, 67(6), 953-957.

Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H., & Verpoorte, R. (2010). Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry, 71(17-18), 2058-2073.

Hazekamp, A., & Grotenhermen, F. (2010). Review on clinical studies with cannabis and cannabinoids 2005-2009. Cannabinoids, 5(special issue), 1-21.

Hazekamp, A., Ware, M. A., Muller-Vahl, K. R., Abrams, D., & Grotenhermen, F. (2013). The medicinal use of cannabis and cannabinoids—an international cross-sectional survey on administration forms. Journal of psychoactive drugs, 45(3), 199-210.

Hazekamp, A., Peltenburg, A., Verpoorte, R., & Giroud, C. (2005). Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa L. Journal of liquid chromatography & related technologies, 28(15), 2361-2382.

Hazekamp, A., Choi, Y. H., & Verpoorte, R. (2004). Quantitative analysis of cannabinoids from Cannabis sativa using 1H-NMR. Chemical and pharmaceutical bulletin, 52(6), 718-721.

Hazekamp, A., & Heerdink, E. R. (2013). The prevalence and incidence of medicinal cannabis on prescription in The Netherlands. European journal of clinical pharmacology, 69(8), 1575-1580.

Hazekamp, A., Simons, R., Peltenburg‐Looman, A., Sengers, M., van Zweden, R., & Verpoorte, R. (2004). Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography. Journal of liquid chromatography & related technologies, 27(15), 2421-2439.

Hazekamp, A., Ruhaak, R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006). Evaluation of a vaporizing device (Volcano®) for the pulmonary administration of tetrahydrocannabinol. Journal of pharmaceutical sciences, 95(6), 1308-1317.

Hazekamp, A., Sijrier, P., & Verpoorte, R. (2006). An evaluation of the quality of medicinal grade cannabis in the Netherlands. Cannabinoids, 1(1), 1-9.

Choi, Y. H., Hazekamp, A., Peltenburg‐Looman, A. M., Frédérich, M., Erkelens, C., Lefeber, A. W., & Verpoorte, R. (2004). NMR assignments of the major cannabinoids and cannabiflavonoids isolated from flowers of Cannabis sativa. Phytochemical Analysis: An International Journal of Plant Chemical and Biochemical Techniques, 15(6), 345-354.

Hazekamp, A., Bastola, K., Rashidi, H., Bender, J., & Verpoorte, R. (2007). Cannabis tea revisited: a systematic evaluation of the cannabinoid composition of cannabis tea. Journal of ethnopharmacology, 113(1), 85-90.

Romano, L. L., & Hazekamp, A. (2013). Cannabis oil: chemical evaluation of an upcoming cannabis-based medicine. Cannabinoids, 1(1), 1-11.

Fischedick, J. T., Glas, R., Hazekamp, A., & Verpoorte, R. (2009). A qualitative and quantitative HPTLC densitometry method for the analysis of cannabinoids in Cannabis sativa L. Phytochemical analysis, 20(5), 421-426.

Hazekamp, A., & Verpoorte, R. (2006). Structure elucidation of the tetrahydrocannabinol complex with randomly methylated β-cyclodextrin. European journal of pharmaceutical sciences, 29(5), 340-347.

Solowij, N., Broyd, S. J., van Hell, H. H., & Hazekamp, A. (2014). A protocol for the delivery of cannabidiol (CBD) and combined CBD and∆ 9-tetrahydrocannabinol (THC) by vaporisation. BMC Pharmacology and Toxicology, 15(1), 58.

Kowal, M. A., Hazekamp, A., & Grotenhermen, F. (2016). Review on clinical studies with cannabis and cannabinoids 2010-2014. Multiple sclerosis, 6(1515), 202010-2014.

Hazekamp, A., Tejkalová, K., & Papadimitriou, S. (2016). Cannabis: from cultivar to chemovar II—a metabolomics approach to Cannabis classification. Cannabis and Cannabinoid Research, 1(1), 202-215.

Hazekamp, A. (2008). Cannabis review. Department of Plant Metobolomics, Leiden University, 2009.

Monnet-Tschudi, F., Hazekamp, A., Perret, N., Zurich, M. G., Mangin, P., Giroud, C., & Honegger, P. (2008). Delta-9-tetrahydrocannabinol accumulation, metabolism and cell-type-specific adverse effects in aggregating brain cell cultures. Toxicology and applied pharmacology, 228(1), 8-16.

Hazekamp, A. (2007). Cannabis; extracting the medicine. Department of Pharmacognosy,(IBL), Faculty of Science, Leiden University.

Kowal, M. A., Hazekamp, A., Colzato, L. S., Van Steenbergen, H., & Hommel, B. (2013). Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex. Frontiers in human neuroscience, 7, 147.

Erkelens, J. L., & Hazekamp, A. (2014). That which we call Indica, by any other name would smell as sweet. Cannabinoids, 9(1), 9-15.

Hazekamp, A. (2016). Evaluating the effects of gamma-irradiation for decontamination of medicinal cannabis. Frontiers in pharmacology, 7, 108.

Bastola, K. P., Hazekamp, A., & Verpoorte, R. (2007). Synthesis and spectroscopic characterization of cannabinolic acid. Planta medica, 73(3), 273.

Hazekamp, A., & Pappas, G. (2014). Self-medication with cannabis. Handbook of Cannabis, 319.

de Hoop, B., Heerdink, E. R., & Hazekamp, A. (2018). Medicinal Cannabis on Prescription in The Netherlands: Statistics for 2003–2016. Cannabis and cannabinoid research, 3(1), 54-55.

Hazekamp, A., & Grotenhermen, F. (2013). Clinical Studies With Cannabis and Cannabinoids, 2005-2009.

Hazekamp, A. (2018). The Trouble with CBD Oil. Medical Cannabis and Cannabinoids, 1(1), 65-72.